Short Description Amylyx Pharmaceuticals develops combination therapy for als to support healthy longevity.
Description Amylyx Pharmaceuticals is a biotechnology innovator targeting the fundamental mechanisms of aging through combination therapy for als. The company leverages advancements in neurodegeneration and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Amylyx Pharmaceuticals aims to extend healthspan and improve quality of life across the globe.
Address 43 Thorndike St, Cambridge, MA, USA